Northern Trust Corp Surmodics Inc Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Surmodics Inc stock. As of the latest transaction made, Northern Trust Corp holds 135,010 shares of SRDX stock, worth $4.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,010

Previous 129,337 4.39%

Holding current value

$4.64 Million

Previous $5.02 Million 6.6%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$37.5 - $40.13 $212,737 - $227,657	5,673 Added 4.39%	135,010 $5.35 Million
Q3 2024 Nov 13, 2024	BUY	$38.47 - $42.24 $107,600 - $118,145	2,797 Added 2.21%	129,337 $5.02 Million
Q2 2024 Aug 14, 2024	SELL	$25.39 - $42.1 $159,906 - $265,145	-6,298 Reduced 4.74%	126,540 $5.32 Million
Q1 2024 May 14, 2024	SELL	$27.44 - $35.56 $120,351 - $155,966	-4,386 Reduced 3.2%	132,838 $3.9 Million
Q4 2023 Feb 13, 2024	BUY	$28.47 - $38.49 $6,861 - $9,276	241 Added 0.18%	137,224 $4.99 Million
Q3 2023 Nov 13, 2023	BUY	$28.28 - $38.36 $53,958 - $73,190	1,908 Added 1.41%	136,983 $4.4 Million
Q2 2023 Aug 11, 2023	SELL	$17.67 - $31.31 $792,093 - $1.4 Million	-44,827 Reduced 24.92%	135,075 $4.23 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $187,299 - $421,177	10,934 Added 6.47%	179,902 $4.1 Million
Q4 2022 Feb 13, 2023	BUY	$29.44 - $37.31 $238,051 - $301,688	8,086 Added 5.03%	168,968 $5.77 Million
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $8,392 - $11,325	-291 Reduced 0.18%	160,882 $4.89 Million
Q2 2022 Aug 12, 2022	SELL	$33.25 - $45.11 $90,174 - $122,338	-2,712 Reduced 1.65%	161,173 $6 Million
Q1 2022 May 13, 2022	SELL	$40.68 - $49.72 $278,739 - $340,681	-6,852 Reduced 4.01%	163,885 $7.43 Million
Q4 2021 Feb 08, 2022	SELL	$43.21 - $57.6 $219,722 - $292,896	-5,085 Reduced 2.89%	170,737 $8.22 Million
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $22,492 - $25,696	426 Added 0.24%	175,822 $9.78 Million
Q2 2021 Aug 13, 2021	BUY	$51.29 - $59.15 $57,803 - $66,662	1,127 Added 0.65%	175,396 $9.52 Million
Q1 2021 May 12, 2021	SELL	$42.18 - $56.07 $442,847 - $588,678	-10,499 Reduced 5.68%	174,269 $9.77 Million
Q4 2020 Feb 11, 2021	SELL	$35.18 - $43.52 $214,738 - $265,646	-6,104 Reduced 3.2%	184,768 $8.04 Million
Q3 2020 Nov 16, 2020	SELL	$37.98 - $48.72 $323,399 - $414,850	-8,515 Reduced 4.27%	190,872 $7.43 Million
Q2 2020 Aug 14, 2020	BUY	$31.07 - $44.74 $222,585 - $320,517	7,164 Added 3.73%	199,387 $8.62 Million
Q1 2020 May 14, 2020	BUY	$22.46 - $42.24 $39,686 - $74,638	1,767 Added 0.93%	192,223 $6.41 Million
Q4 2019 Feb 14, 2020	SELL	$39.01 - $47.51 $216,115 - $263,205	-5,540 Reduced 2.83%	190,456 $7.89 Million
Q3 2019 Nov 13, 2019	BUY	$38.66 - $47.41 $173,815 - $213,155	4,496 Added 2.35%	195,996 $8.97 Million
Q2 2019 Aug 13, 2019	BUY	$38.23 - $47.43 $25,652 - $31,825	671 Added 0.35%	191,500 $8.27 Million
Q1 2019 May 13, 2019	BUY	$41.26 - $58.35 $105,790 - $149,609	2,564 Added 1.36%	190,829 $8.3 Million
Q4 2018 Feb 12, 2019	SELL	$44.93 - $73.38 $69,776 - $113,959	-1,553 Reduced 0.82%	188,265 $8.9 Million
Q3 2018 Nov 14, 2018	BUY	$56.85 - $80.35 $180,271 - $254,789	3,171 Added 1.7%	189,818 $14.2 Million
Q2 2018 Sep 18, 2018	SELL	$35.85 - $57.05 $30,114 - $47,922	-840 Reduced 0.45%	186,647 $10.3 Million
Q2 2018 Aug 14, 2018	BUY	$35.85 - $57.05 $106,259 - $169,096	2,964 Added 1.61%	187,487 $10.4 Million
Q1 2018 May 09, 2018	BUY	$27.0 - $38.5 $86,481 - $123,315	3,203 Added 1.77%	184,523 $7.02 Million
Q4 2017 Feb 14, 2018	SELL	$28.0 - $33.2 $100,380 - $119,022	-3,585 Reduced 1.94%	181,320 $5.08 Million
Q3 2017 Nov 13, 2017	BUY	$24.5 - $31.1 $4.53 Million - $5.75 Million	184,905	184,905 $5.73 Million

Others Institutions Holding SRDX

# of Institutions

141

Shares Held

12M

Call Options Held

31.4K

Put Options Held

13.2K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $481M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Surmodics Inc Transaction History